Death rattle: Critical review and research agenda

Supportive Care in Cancer

Volumn 22, Issue 2, 2014, Pages 571-575

  Mercadamte, Sebastiano ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

Anticholinergics; Bronchial secretions; Death rattle; End of life; Palliative care

Indexed keywords

ATROPINE; GLYCOPYRRONIUM BROMIDE; OCTREOTIDE;

BRONCHUS SECRETION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DEATH RATTLE; HUMAN; INTENTION TO TREAT ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TERMINAL CARE;

CHOLINERGIC ANTAGONISTS; DEATH; HUMANS; MUSCARINIC ANTAGONISTS; PALLIATIVE CARE; RESPIRATORY SOUNDS; TERMINAL CARE;

EID: 84896050172     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2047-5     Document Type: Review

References (22)

1. Bennett M, Lucas V, Brennan M, Hughes A, O'Donnell V, Wee B (2002) Association for Palliative Medicine's Science Committee. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med 16:369-74
2. Wildiers H, Menten J (2002) Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 23:310-7
3. Morita T, Tsunoda J, Inoue S et al (2000) Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study. Palliat Med 14:19-23
4. Kaas RM, Ellershaw J (2003) Respiratory tract secretions in the dying patient: a retrospective study. J Pain Symptom Manage 26: 897-902
5. Wee B, Coleman P, Hillier R et al (2006) The sound of death rattle. II: how do relative interpret the sound. Palliat Med 20:177-181
6. Martinsson L, Fürst CJ, Lundström S, Nathanaelsson L, Axelsson B. (2012) Registration in a quality register: a method to improve end-of-life care - a cross-sectional study. BMJ Open Aug 30;2 (4)
7. Wee B, Hillier R (2008) Interventions for noisy breathing in patid review of management. Cochrane Database Syst Rev 1, CD005177
8. Hirsch CA, Marriott JF, Faull CM (2013) Influences on the decision to prescribe or administer anticholinergic drugs to treat death rattle: a focus group study. Palliat Med 27:732-738
9. Wildiers H, Dhaenekint C, Demeulenacre P et al (2009) Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage 38:124-133
10. Heisler M, Hamilton G, Abbott A et al (2013) Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle. J Pain Symptom Manage 45:14-22
11. Clark K, Currow DC, Agar M et al (2008) A pilot phase II randomized, cross-over, double-blind, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end of life. J Pain Palliat Care Pharmacother 22:131-138
12. Likar R, Rupacher E, Kager H et al (2008) Comparing the efficacy of glycopirronium bromide and scopolamine hydro bromide in patients with death rattle. A prospective randomized study. Mid Eur J Med 120:679-83
13. Hughes A, Wilcock A, Corcoran R et al (2000) Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med 14:221-2
14. Back IN, Jenkins K, Blower A et al (2001) A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 15:329-36
15. Hughel H, Ellershaw J, Gambles MR (2006) Espiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. J Palliat Med 8:279-284
16. Protus BM, Grauer PA, Kimbrel J (2012) Evaluation of atropine 1% opthalmic solution administered sublingually for the management of terminal respiratory secretions. Pall Med 30:388-392
17. Mercadante S, Villari P, Ferrera P (2011) Refractory death rattle: deep aspiration facilitates the effects of antisecretory agents. J Pain Symptom Manage 41:637-9
18. Morita T, Hyodo I, Yoshomi T et al (2005) Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 16:640-647
19. Mercadante S, Valle A, Porzio G et al (2011) How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manage 42:702-9
20. Prommer E (2013) Anticholinergics in palliative medicine: an update. Am J Hosp Pall Med 30:490-8
21. Yamaguchi T, Morita T, Shinjo T (2012) Effect of parenteral hydration therapy based on the Japanese National Clinical Guideline on quality of life, discomfort, and symptom intensity in patients with advanced cancer. J Pain Symptom Manage 43:1001-1012
22. Mercadante S, Intravaia G, Villari P et al (2009) Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage 37:771-9